Td Asset Management Inc Fibrogen Inc Transaction History

Td Asset Management Inc

$107 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	SELL	$15.95 - $25.18 $397,155 - $626,982	-24,900 Reduced 67.85%	11,800 $220,000
Q4 2022 Feb 06, 2023	BUY	$13.27 - $17.73 $487,009 - $650,691	36,700 New	36,700 $587,000
Q2 2021 Aug 11, 2021	SELL	$18.57 - $35.68 $1.05 Million - $2.02 Million	-56,726 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$31.0 - $55.72 $793,600 - $1.43 Million	-25,600 Reduced 31.1%	56,726 $1.97 Million
Q4 2020 Feb 16, 2021	SELL	$37.09 - $48.97 $185,450 - $244,850	-5,000 Reduced 5.73%	82,326 $3.05 Million
Q3 2020 Nov 10, 2020	BUY	$40.47 - $45.5 $424,935 - $477,750	10,500 Added 13.67%	87,326 $3.59 Million
Q2 2020 Aug 13, 2020	BUY	$32.57 - $42.83 $1.19 Million - $1.56 Million	36,400 Added 90.04%	76,826 $3.11 Million
Q1 2020 May 15, 2020	SELL	$23.3 - $45.96 $205,040 - $404,448	-8,800 Reduced 17.88%	40,426 $1.41 Million
Q4 2019 Feb 11, 2020	SELL	$34.58 - $48.06 $79,534 - $110,538	-2,300 Reduced 4.46%	49,226 $2.11 Million
Q2 2019 Aug 01, 2019	SELL	$35.13 - $55.53 $28,104 - $44,424	-800 Reduced 1.53%	51,526 $2.33 Million
Q1 2019 May 08, 2019	BUY	$42.83 - $59.91 $252,697 - $353,469	5,900 Added 12.71%	52,326 $2.84 Million
Q4 2018 Feb 01, 2019	SELL	$37.97 - $60.16 $22,782 - $36,096	-600 Reduced 1.28%	46,426 $2.15 Million
Q3 2018 Nov 01, 2018	BUY	$56.3 - $67.25 $33,780 - $40,350	600 Added 1.29%	47,026 $2.86 Million
Q2 2018 Jul 31, 2018	BUY	$44.9 - $64.95 $350,220 - $506,610	7,800 Added 20.19%	46,426 $2.91 Million
Q1 2018 May 11, 2018	BUY	$45.35 - $61.65 $258,495 - $351,405	5,700 Added 17.31%	38,626 $1.79 Million
Q4 2017 Feb 02, 2018	BUY	$41.95 - $60.1 $41,950 - $60,100	1,000 Added 3.13%	32,926 $1.56 Million
Q3 2017 Nov 09, 2017	BUY	$33.4 - $53.9 $1.07 Million - $1.72 Million	31,926	31,926 $1.72 Million

Others Institutions Holding FGEN

# of Institutions

Shares Held

47.1M

Call Options Held

387K

Put Options Held

672K

Primecap Management CO Pasadena, CA

9.91M
Shares

$3.47 Million
0.0% of portfolio
Armistice Capital, LLC New York, NY

6.8M
Shares

$2.38 Million
0.05% of portfolio
Vanguard Group Inc Valley Forge, PA

5.88M
Shares

$2.06 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

3.91M
Shares

$1.37 Million
0.0% of portfolio
Black Rock Inc. New York, NY

2.41M
Shares

$843,377
0.0% of portfolio

View Full List

About FIBROGEN INC

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $32.8M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

More about FGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.

Account